1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Next-generation Sequencing (NGS) 1.2.3 Polymerase Chain Reaction (PCR) 1.2.4 Immunohistochemistry (IHC) 1.2.5 In Situ Hybridization (ISH) 1.2.6 Microarray 1.2.7 Others 1.3 Market by Application 1.3.1 Global Cancer Tumor Profiling Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Personalized Medicine 1.3.3 Diagnostics 1.3.4 Biomarker Discovery 1.3.5 Prognostics 1.3.6 Research Applications 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Tumor Profiling Market Perspective (2016-2027) 2.2 Cancer Tumor Profiling Growth Trends by Regions 2.2.1 Cancer Tumor Profiling Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2016-2021) 2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2022-2027) 2.3 Cancer Tumor Profiling Industry Dynamic 2.3.1 Cancer Tumor Profiling Market Trends 2.3.2 Cancer Tumor Profiling Market Drivers 2.3.3 Cancer Tumor Profiling Market Challenges 2.3.4 Cancer Tumor Profiling Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Tumor Profiling Players by Revenue 3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2016-2021) 3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2016-2021) 3.2 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue 3.4 Global Cancer Tumor Profiling Market Concentration Ratio 3.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2020 3.5 Cancer Tumor Profiling Key Players Head office and Area Served 3.6 Key Players Cancer Tumor Profiling Product Solution and Service 3.7 Date of Enter into Cancer Tumor Profiling Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Tumor Profiling Breakdown Data by Type 4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2016-2021) 4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2022-2027) 5 Cancer Tumor Profiling Breakdown Data by Application 5.1 Global Cancer Tumor Profiling Historic Market Size by Application (2016-2021) 5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cancer Tumor Profiling Market Size (2016-2027) 6.2 North America Cancer Tumor Profiling Market Size by Type 6.2.1 North America Cancer Tumor Profiling Market Size by Type (2016-2021) 6.2.2 North America Cancer Tumor Profiling Market Size by Type (2022-2027) 6.2.3 North America Cancer Tumor Profiling Market Size by Type (2016-2027) 6.3 North America Cancer Tumor Profiling Market Size by Application 6.3.1 North America Cancer Tumor Profiling Market Size by Application (2016-2021) 6.3.2 North America Cancer Tumor Profiling Market Size by Application (2022-2027) 6.3.3 North America Cancer Tumor Profiling Market Size by Application (2016-2027) 6.4 North America Cancer Tumor Profiling Market Size by Country 6.4.1 North America Cancer Tumor Profiling Market Size by Country (2016-2021) 6.4.2 North America Cancer Tumor Profiling Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cancer Tumor Profiling Market Size (2016-2027) 7.2 Europe Cancer Tumor Profiling Market Size by Type 7.2.1 Europe Cancer Tumor Profiling Market Size by Type (2016-2021) 7.2.2 Europe Cancer Tumor Profiling Market Size by Type (2022-2027) 7.2.3 Europe Cancer Tumor Profiling Market Size by Type (2016-2027) 7.3 Europe Cancer Tumor Profiling Market Size by Application 7.3.1 Europe Cancer Tumor Profiling Market Size by Application (2016-2021) 7.3.2 Europe Cancer Tumor Profiling Market Size by Application (2022-2027) 7.3.3 Europe Cancer Tumor Profiling Market Size by Application (2016-2027) 7.4 Europe Cancer Tumor Profiling Market Size by Country 7.4.1 Europe Cancer Tumor Profiling Market Size by Country (2016-2021) 7.4.2 Europe Cancer Tumor Profiling Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cancer Tumor Profiling Market Size (2016-2027) 8.2 Asia-Pacific Cancer Tumor Profiling Market Size by Type 8.2.1 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2027) 8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Application 8.3.1 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2027) 8.4 Asia-Pacific Cancer Tumor Profiling Market Size by Region 8.4.1 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cancer Tumor Profiling Market Size (2016-2027) 9.2 Latin America Cancer Tumor Profiling Market Size by Type 9.2.1 Latin America Cancer Tumor Profiling Market Size by Type (2016-2021) 9.2.2 Latin America Cancer Tumor Profiling Market Size by Type (2022-2027) 9.2.3 Latin America Cancer Tumor Profiling Market Size by Type (2016-2027) 9.3 Latin America Cancer Tumor Profiling Market Size by Application 9.3.1 Latin America Cancer Tumor Profiling Market Size by Application (2016-2021) 9.3.2 Latin America Cancer Tumor Profiling Market Size by Application (2022-2027) 9.3.3 Latin America Cancer Tumor Profiling Market Size by Application (2016-2027) 9.4 Latin America Cancer Tumor Profiling Market Size by Country 9.4.1 Latin America Cancer Tumor Profiling Market Size by Country (2016-2021) 9.4.2 Latin America Cancer Tumor Profiling Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Tumor Profiling Market Size (2016-2027) 10.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type 10.2.1 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2027) 10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application 10.3.1 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2027) 10.4 Middle East & Africa Cancer Tumor Profiling Market Size by Country 10.4.1 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Qiagen N.V. 11.1.1 Qiagen N.V. Company Details 11.1.2 Qiagen N.V. Business Overview 11.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction 11.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.1.5 Qiagen N.V. Recent Development 11.2 Roche Molecular Systems Inc. 11.2.1 Roche Molecular Systems Inc. Company Details 11.2.2 Roche Molecular Systems Inc. Business Overview 11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction 11.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.2.5 Roche Molecular Systems Inc. Recent Development 11.3 Abott Molecular 11.3.1 Abott Molecular Company Details 11.3.2 Abott Molecular Business Overview 11.3.3 Abott Molecular Cancer Tumor Profiling Introduction 11.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2016-2021) 11.3.5 Abott Molecular Recent Development 11.4 Illumina Inc. 11.4.1 Illumina Inc. Company Details 11.4.2 Illumina Inc. Business Overview 11.4.3 Illumina Inc. Cancer Tumor Profiling Introduction 11.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.4.5 Illumina Inc. Recent Development 11.5 NeoGenomics Laboratories 11.5.1 NeoGenomics Laboratories Company Details 11.5.2 NeoGenomics Laboratories Business Overview 11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction 11.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2016-2021) 11.5.5 NeoGenomics Laboratories Recent Development 11.6 HTG Molecular Diagnostic 11.6.1 HTG Molecular Diagnostic Company Details 11.6.2 HTG Molecular Diagnostic Business Overview 11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction 11.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2016-2021) 11.6.5 HTG Molecular Diagnostic Recent Development 11.7 Genomic Health Inc. 11.7.1 Genomic Health Inc. Company Details 11.7.2 Genomic Health Inc. Business Overview 11.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction 11.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.7.5 Genomic Health Inc. Recent Development 11.8 Hologic Gen-Probe 11.8.1 Hologic Gen-Probe Company Details 11.8.2 Hologic Gen-Probe Business Overview 11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction 11.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2016-2021) 11.8.5 Hologic Gen-Probe Recent Development 11.9 BD Biosciences 11.9.1 BD Biosciences Company Details 11.9.2 BD Biosciences Business Overview 11.9.3 BD Biosciences Cancer Tumor Profiling Introduction 11.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2016-2021) 11.9.5 BD Biosciences Recent Development 11.10 Siemens Healthineers 11.10.1 Siemens Healthineers Company Details 11.10.2 Siemens Healthineers Business Overview 11.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction 11.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2016-2021) 11.10.5 Siemens Healthineers Recent Development 11.11 Claris Life Sciences 11.11.1 Claris Life Sciences Company Details 11.11.2 Claris Life Sciences Business Overview 11.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction 11.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2016-2021) 11.11.5 Claris Life Sciences Recent Development 11.12 Personal Genome Diagnostics, Inc. 11.12.1 Personal Genome Diagnostics, Inc. Company Details 11.12.2 Personal Genome Diagnostics, Inc. Business Overview 11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction 11.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.12.5 Personal Genome Diagnostics, Inc. Recent Development 11.13 Perthera, Inc. 11.13.1 Perthera, Inc. Company Details 11.13.2 Perthera, Inc. Business Overview 11.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction 11.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) 11.13.5 Perthera, Inc. Recent Development 11.14 Foundation Medicine, Inc 11.14.1 Foundation Medicine, Inc Company Details 11.14.2 Foundation Medicine, Inc Business Overview 11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction 11.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2016-2021) 11.14.5 Foundation Medicine, Inc Recent Development 11.15 V., Strand 11.15.1 V., Strand Company Details 11.15.2 V., Strand Business Overview 11.15.3 V., Strand Cancer Tumor Profiling Introduction 11.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2016-2021) 11.15.5 V., Strand Recent Development 11.16 ApoCell 11.16.1 ApoCell Company Details 11.16.2 ApoCell Business Overview 11.16.3 ApoCell Cancer Tumor Profiling Introduction 11.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2016-2021) 11.16.5 ApoCell Recent Development 11.17 Contextual Genomics 11.17.1 Contextual Genomics Company Details 11.17.2 Contextual Genomics Business Overview 11.17.3 Contextual Genomics Cancer Tumor Profiling Introduction 11.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2016-2021) 11.17.5 Contextual Genomics Recent Development 11.18 Agendia 11.18.1 Agendia Company Details 11.18.2 Agendia Business Overview 11.18.3 Agendia Cancer Tumor Profiling Introduction 11.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2016-2021) 11.18.5 Agendia Recent Development 11.18 GenScript .1 GenScript Company Details .2 GenScript Business Overview .3 GenScript Cancer Tumor Profiling Introduction .4 GenScript Revenue in Cancer Tumor Profiling Business (2016-2021) .5 GenScript Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Next-generation Sequencing (NGS) Table 3. Key Players of Polymerase Chain Reaction (PCR) Table 4. Key Players of Immunohistochemistry (IHC) Table 5. Key Players of In Situ Hybridization (ISH) Table 6. Key Players of Microarray Table 7. Key Players of Others Table 8. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Cancer Tumor Profiling Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Cancer Tumor Profiling Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Cancer Tumor Profiling Market Share by Regions (2016-2021) Table 12. Global Cancer Tumor Profiling Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Cancer Tumor Profiling Market Share by Regions (2022-2027) Table 14. Cancer Tumor Profiling Market Trends Table 15. Cancer Tumor Profiling Market Drivers Table 16. Cancer Tumor Profiling Market Challenges Table 17. Cancer Tumor Profiling Market Restraints Table 18. Global Cancer Tumor Profiling Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Cancer Tumor Profiling Market Share by Players (2016-2021) Table 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2020) Table 21. Ranking of Global Top Cancer Tumor Profiling Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Cancer Tumor Profiling Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Tumor Profiling Product Solution and Service Table 25. Date of Enter into Cancer Tumor Profiling Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 28. Global Cancer Tumor Profiling Revenue Market Share by Type (2016-2021) Table 29. Global Cancer Tumor Profiling Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Cancer Tumor Profiling Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Cancer Tumor Profiling Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Cancer Tumor Profiling Revenue Market Share by Application (2016-2021) Table 33. Global Cancer Tumor Profiling Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Cancer Tumor Profiling Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 36. North America Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million) Table 38. North America Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million) Table 65. Qiagen N.V. Company Details Table 66. Qiagen N.V. Business Overview Table 67. Qiagen N.V. Cancer Tumor Profiling Product Table 68. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 69. Qiagen N.V. Recent Development Table 70. Roche Molecular Systems Inc. Company Details Table 71. Roche Molecular Systems Inc. Business Overview Table 72. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Table 73. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 74. Roche Molecular Systems Inc. Recent Development Table 75. Abott Molecular Company Details Table 76. Abott Molecular Business Overview Table 77. Abott Molecular Cancer Tumor Profiling Product Table 78. Abott Molecular Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 79. Abott Molecular Recent Development Table 80. Illumina Inc. Company Details Table 81. Illumina Inc. Business Overview Table 82. Illumina Inc. Cancer Tumor Profiling Product Table 83. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 84. Illumina Inc. Recent Development Table 85. NeoGenomics Laboratories Company Details Table 86. NeoGenomics Laboratories Business Overview Table 87. NeoGenomics Laboratories Cancer Tumor Profiling Product Table 88. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 89. NeoGenomics Laboratories Recent Development Table 90. HTG Molecular Diagnostic Company Details Table 91. HTG Molecular Diagnostic Business Overview Table 92. HTG Molecular Diagnostic Cancer Tumor Profiling Product Table 93. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 94. HTG Molecular Diagnostic Recent Development Table 95. Genomic Health Inc. Company Details Table 96. Genomic Health Inc. Business Overview Table 97. Genomic Health Inc. Cancer Tumor Profiling Product Table 98. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 99. Genomic Health Inc. Recent Development Table 100. Hologic Gen-Probe Company Details Table 101. Hologic Gen-Probe Business Overview Table 102. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 103. Hologic Gen-Probe Recent Development Table 104. BD Biosciences Company Details Table 105. BD Biosciences Business Overview Table 106. BD Biosciences Cancer Tumor Profiling Product Table 107. BD Biosciences Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 108. BD Biosciences Recent Development Table 109. Siemens Healthineers Company Details Table 110. Siemens Healthineers Business Overview Table 111. Siemens Healthineers Cancer Tumor Profiling Product Table 112. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 113. Siemens Healthineers Recent Development Table 114. Claris Life Sciences Company Details Table 115. Claris Life Sciences Business Overview Table 116. Claris Life Sciences Cancer Tumor Profiling Product Table 117. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 118. Claris Life Sciences Recent Development Table 119. Personal Genome Diagnostics, Inc. Company Details Table 120. Personal Genome Diagnostics, Inc. Business Overview Table 121. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Table 122. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 123. Personal Genome Diagnostics, Inc. Recent Development Table 124. Perthera, Inc. Company Details Table 125. Perthera, Inc. Business Overview Table 126. Perthera, Inc. Cancer Tumor Profiling Product Table 127. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 128. Perthera, Inc. Recent Development Table 129. Foundation Medicine, Inc Company Details Table 130. Foundation Medicine, Inc Business Overview Table 131. Foundation Medicine, Inc Cancer Tumor Profiling Product Table 132. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 133. Foundation Medicine, Inc Recent Development Table 134. V., Strand Company Details Table 135. V., Strand Business Overview Table 136. V., Strand Cancer Tumor Profiling Product Table 137. V., Strand Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 138. V., Strand Recent Development Table 139. ApoCell Company Details Table 140. ApoCell Business Overview Table 141. ApoCell Cancer Tumor Profiling Product Table 142. ApoCell Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 143. ApoCell Recent Development Table 144. Contextual Genomics Company Details Table 145. Contextual Genomics Business Overview Table 146. Contextual Genomics Cancer Tumor Profiling Product Table 147. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 148. Contextual Genomics Recent Development Table 149. Agendia Company Details Table 150. Agendia Business Overview Table 151. Agendia Cancer Tumor Profiling Product Table 152. Agendia Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 153. Agendia Recent Development Table 154. GenScript Company Details Table 155. GenScript Business Overview Table 156. GenScript Cancer Tumor Profiling Product Table 157. GenScript Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million) Table 158. GenScript Recent Development Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Tumor Profiling Market Share by Type: 2020 VS 2027 Figure 2. Next-generation Sequencing (NGS) Features Figure 3. Polymerase Chain Reaction (PCR) Features Figure 4. Immunohistochemistry (IHC) Features Figure 5. In Situ Hybridization (ISH) Features Figure 6. Microarray Features Figure 7. Others Features Figure 8. Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2027 Figure 9. Personalized Medicine Case Studies Figure 10. Diagnostics Case Studies Figure 11. Biomarker Discovery Case Studies Figure 12. Prognostics Case Studies Figure 13. Research Applications Case Studies Figure 14. Cancer Tumor Profiling Report Years Considered Figure 15. Global Cancer Tumor Profiling Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Cancer Tumor Profiling Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Cancer Tumor Profiling Market Share by Regions: 2020 VS 2027 Figure 18. Global Cancer Tumor Profiling Market Share by Regions (2022-2027) Figure 19. Global Cancer Tumor Profiling Market Share by Players in 2020 Figure 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2020 Figure 22. Global Cancer Tumor Profiling Revenue Market Share by Type (2016-2021) Figure 23. Global Cancer Tumor Profiling Revenue Market Share by Type (2022-2027) Figure 24. North America Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Cancer Tumor Profiling Market Share by Type (2016-2027) Figure 26. North America Cancer Tumor Profiling Market Share by Application (2016-2027) Figure 27. North America Cancer Tumor Profiling Market Share by Country (2016-2027) Figure 28. United States Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Cancer Tumor Profiling Market Share by Type (2016-2027) Figure 32. Europe Cancer Tumor Profiling Market Share by Application (2016-2027) Figure 33. Europe Cancer Tumor Profiling Market Share by Country (2016-2027) Figure 34. Germany Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Cancer Tumor Profiling Market Share by Type (2016-2027) Figure 42. Asia-Pacific Cancer Tumor Profiling Market Share by Application (2016-2027) Figure 43. Asia-Pacific Cancer Tumor Profiling Market Share by Region (2016-2027) Figure 44. China Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Cancer Tumor Profiling Market Share by Type (2016-2027) Figure 52. Latin America Cancer Tumor Profiling Market Share by Application (2016-2027) Figure 53. Latin America Cancer Tumor Profiling Market Share by Country (2016-2027) Figure 54. Mexico Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Cancer Tumor Profiling Market Share by Type (2016-2027) Figure 58. Middle East & Africa Cancer Tumor Profiling Market Share by Application (2016-2027) Figure 59. Middle East & Africa Cancer Tumor Profiling Market Share by Country (2016-2027) Figure 60. Turkey Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 64. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 65. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 66. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 67. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 68. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 69. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 70. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 71. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 72. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 73. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 74. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 75. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 76. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 77. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 78. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 79. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 80. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 81. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021) Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

Qiagen N.V. Roche Molecular Systems Inc. Abott Molecular Illumina Inc. NeoGenomics Laboratories HTG Molecular Diagnostic Genomic Health Inc. Hologic Gen-Probe BD Biosciences Siemens Healthineers Claris Life Sciences Personal Genome Diagnostics, Inc. Perthera, Inc. Foundation Medicine, Inc V., Strand ApoCell Contextual Genomics Agendia GenScript